Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions Most orbital space-occupying lesions come from tissues in the orbital space or metastasize from other system tumors. The bulk of clinical manifestations of these lesions such as diplopia, protrusion, and loss of vision are often nonspecific, so imaging technology is crucial
Tag: ophthalmologist
Risk Factors for Ocular Metastases in Invasive Ductal Carcinoma
Myelofibrosis – Biology, Management, and Case Report of Ocular Manifestation
MF-BIOLOGY, MANAGEMENT, AND CASE REPORT OF OCULAR MANIFESTATION Myelofibrosis is an uncommon myeloproliferative neoplasm, a type of blood cancer where excess red blood cells, white blood cells, or platelets are produced in the bone marrow. The rarity of this abnormality has many medical professionals struggling to understand its genetic underpinnings. This
Study on the Ocular involvement in metastatic and systemic malignancies
Ocular Involvement of Systemic Malignancies Systemic malignancies affecting the eye often involve the choroid or the orbital area of the eye, leading to different ocular manifestations. Ocular malignancies are relatively rare compared to malignancies of other parts of the human body. The American Cancer Society estimates there will be about 3,300 new eye cancer
Using Nanofiber Antibiotic Sutures Prevent Ophthalmic Infections
Using Nanofiber Antibiotic Sutures to Prevent Ophthalmic Infections Sutures are medical devices applied on the site of injury or surgery. Sutures prevent infection, minimize scarring, and fasten recovery. As of today, the only drug-eluting sutures available for antibacterial application in most surgeries are coated with >triclosan. It’s known that putting drugs
Meta-Analysis to Determine Optimal Therapy Strategies in Macular Degeneration
Meta-Analysis Results of Clinical Trial Aimed at Determining Optimal Therapeutic Strategies for anti-VEGF Therapy in nAMD Background of this Study Neovascular age-related macular degeneration (nAMD) affects as many as 196 million people worldwide, and is a major cause of severe vision problems including blindness. Despite its prevalence, disagreements about the treatment options
Tool for evaluating real world evidence in treatment of retinal disease
Tool for Evaluating RWE in the Treatment of Retinal Disease Randomized clinical trials have long been held as the gold standard for evidence based medical practices. However, there is a growing consciousness about the value of incorporating data from real world evidence (RWE) into clinical decision making. Information from real world sources such
The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure
The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure Around 75 million people suffer from glaucoma, making it the world’s leading eye disorder that causes irreversible blindness. Vision loss in glaucoma patients is often accompanied by the dysfunction of the retinal ganglion cell axons. This is believed to
Use of nanotechnology to deliver topical ophthalmic medications
Use of nanotechnology to deliver topical ophthalmic medications Topical drug delivery systems are widely used in transdermal, mucous membrane, ophthalmic, and otic applications as they are highly versatile, effective, and convenient. However, medication delivery complications such as drug solubility, bioavailability, timed release, and inaccurate physical targeting do exist. Recent advancements in nanotechnology
